Literature DB >> 11319825

Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.

K Nithipatikom1, R F DiCamelli, S Kohler, R J Gumina, J R Falck, W B Campbell, G J Gross.   

Abstract

Arachidonic acid (AA) can be metabolized by cytochrome P450 enzymes to many biologically active compounds including 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids (EETs), their corresponding dihydroxyeicosatrienoic acids (DHETs), as well as 19- and 20-hydroxyeicosatetraenoic acids (HETEs). These eicosanoids are potent regulators of vascular tone. However, their role in the ischemic myocardium has not been well investigated. In this study, we used a gas chromatographic-mass spectrometric technique to analyze total EETs, DHETs, and 20-HETE released into coronary venous plasma during coronary artery occlusion and reperfusion in anesthetized dogs. Pentafluorobenzyl esters (PFB-esters) of EETs and PFB-esters/trimethylsilyl ethers (TMS-ethers) of DHETs and 20-HETE were detected in the negative ion chemical ionization (NICI) using methane as a reagent gas. Under the conditions used, all four regioisomers of EET eluted from the capillary gas chromatographic column at similar retention times while four regioisomers of DHETs and 20-HETE eluted separately. The detection limits in plasma samples are 5 pg for total EETs, 40 pg for DHET, and 15 pg for 20-HETE. 14,15-DHET is the major regioisomer detected in the plasma samples while other regioisomers of DHETs are probably present at too low a concentration for detection. During the first 5 to 15 min of coronary occlusion, a slight decrease in the concentration of EETs, 14,15-DHET, and 20-HETE from the control values was observed in coronary venous plasma. At 60 min of occlusion, their concentrations significantly increased and remained elevated during 5 to 60 min of reperfusion. The concentrations decreased at 120 min of reperfusion. The NICI GC-MS was successfully used as a sensitive technique to determine cP450 metabolites of AA in plasma during prolonged occlusion-reperfusion periods. Furthermore, the results indicate that these metabolites may play a role in mediating ischemic-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319825     DOI: 10.1006/abio.2001.5044

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  25 in total

1.  Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms.

Authors:  Tong Lu; Dan Ye; Xiaoli Wang; John M Seubert; Joan P Graves; J Alyce Bradbury; Darryl C Zeldin; Hon-Chi Lee
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

2.  Effect of Angiotensin II and ACTH on Adrenal Blood Flow in the Male Rat Adrenal Gland In Vivo.

Authors:  Abdul J Shah; Tamas Kriska; Kathryn M Gauthier; John R Falck; William B Campbell
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

3.  Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.

Authors:  Garrett J Gross; Anna Hsu; John R Falck; Kasem Nithipatikom
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

4.  Rapid and simultaneous quantitation of prostanoids by UPLC-MS/MS in rat brain.

Authors:  Jafar Sadik B Shaik; Tricia M Miller; Steven H Graham; Mioara D Manole; Samuel M Poloyac
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

5.  A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury.

Authors:  Uwe Hoff; Gordana Bubalo; Mandy Fechner; Maximilian Blum; Ye Zhu; Andreas Pohlmann; Jan Hentschel; Karen Arakelyan; Erdmann Seeliger; Bert Flemming; Dennis Gürgen; Michael Rothe; Thoralf Niendorf; Vijaya L Manthati; John R Falck; Michael Haase; Wolf-Hagen Schunck; Duska Dragun
Journal:  Acta Physiol (Oxf)       Date:  2019-06-02       Impact factor: 6.311

6.  Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.

Authors:  John M Seubert; Christopher J Sinal; Joan Graves; Laura M DeGraff; J Alyce Bradbury; Craig R Lee; Kerry Goralski; Michelle A Carey; Ayala Luria; John W Newman; Bruce D Hammock; John R Falck; Holly Roberts; Howard A Rockman; Elizabeth Murphy; Darryl C Zeldin
Journal:  Circ Res       Date:  2006-07-20       Impact factor: 17.367

7.  Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent.

Authors:  Jeffrey J Iliff; Nabil J Alkayed
Journal:  Future Neurol       Date:  2009-03-01

8.  Structural characterization of monohydroxyeicosatetraenoic acids and dihydroxy- and trihydroxyeicosatrienoic acids by ESI-FTICR.

Authors:  Lijie Cui; Marilyn A Isbell; Yuttana Chawengsub; John R Falck; William B Campbell; Kasem Nithipatikom
Journal:  J Am Soc Mass Spectrom       Date:  2008-01-31       Impact factor: 3.109

9.  Perturbations in blood phosphatidylcholine and sphingomyelin Fatty Acid composition in a sample population of cigarette smokers.

Authors:  Nicoleta Ionescu; Caterina de Freitas; Allain A Bueno
Journal:  Indian J Clin Biochem       Date:  2013-04-30

10.  Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.

Authors:  Garrett J Gross; Kathryn M Gauthier; Jeannine Moore; John R Falck; Bruce D Hammock; William B Campbell; Kasem Nithipatikom
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.